eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | myasthenia gravis |
| Symptom | C0234119|neuromuscular block |
| Sentences | 2 |
| PubMedID- 22291783 | Sugammadex, used in combination with objective neuromuscular monitoring, can be applied to reverse vecuronium-induced neuromuscular blockade in patients with myasthenia gravis. |
| PubMedID- 26086278 | Background: several previous studies using univariate analysis have suggested that the pre-anaesthetic train-of-four (tof) ratio, concentration of anti-acetylcholine receptor (achr) antibodies and the presence of preoperative generalised muscular involvement are determinants of an increased response to neuromuscular blocking agents (nmbas) in patients with myasthenia gravis. |
Page: 1